All News about Metacrine, Inc. - Common Stock
![](/next-assets/images/schema-image-default.png)
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 01, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/12/27/image36.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/26b574b1-f0c6-485d-9245-fc89c0be922c/small/metacrine-logo-r-transparent-png-png.png)
From Metacrine, Inc.
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2022/12/20/image-entrada_therapeutics.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/06/pipeline_bottom.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/09/07/aapharma.png?width=1200&height=800&fit=crop)
Equillium Buys Inflammatory Bowel Disease Player In All-Stock Deal
September 07, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/12/20/image_3.jpg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Monday's After-Market Session
December 19, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_665.png?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/26b574b1-f0c6-485d-9245-fc89c0be922c/small/metacrine-logo-r-transparent-png-png.png)
Metacrine Reports Third-Quarter 2022 Results
November 14, 2022
From Metacrine, Inc.
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2022/11/10/image_3.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/10/27/image12.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://mms.businesswire.com/media/20221004005889/en/1115287/4/Latest_KSF_M%26A.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/09/28/image45.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/12/shutterstock_1726134715.png)
![](https://mms.businesswire.com/media/20220907006289/en/1115287/4/Latest_KSF_M%26A.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_16393.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220906006102/en/824838/5/Firm_Logo-with_Investor_Law_Firm.jpg)
![](https://mms.businesswire.com/media/20220906005973/en/1322078/4/Equillium_Logo.jpg)
Equillium to Acquire Metacrine in All-Stock Transaction
September 06, 2022
From Equillium, Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/valuestock_image_720.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_3478.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_2147.jpeg)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-pre-market.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/premkt_movers_541.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_356.jpeg)
![](https://images.pexels.com/photos/5849595/pexels-photo-5849595.jpeg?auto=compress&cs=tinysrgb&dpr=1&w=500)
Wingstop, Akamai Initiations Among Today's Top Calls On Wall Street
December 29, 2021
Via Talk Markets
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_358.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/valuestock_image_590.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_352.png)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free